Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Bernhagen,
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
2007, Pubmed
Bernhagen,
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
2007,
Pubmed
Calandra,
Macrophage migration inhibitory factor: a regulator of innate immunity.
2003,
Pubmed
Charo,
The many roles of chemokines and chemokine receptors in inflammation.
2006,
Pubmed
Coleman,
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
2008,
Pubmed
David,
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.
1966,
Pubmed
DeVries,
Defining the origins and evolution of the chemokine/chemokine receptor system.
2006,
Pubmed
,
Echinobase
Furukawa,
Two macrophage migration inhibitory factors regulate starfish larval immune cell chemotaxis.
2016,
Pubmed
,
Echinobase
Leng,
MIF signal transduction initiated by binding to CD74.
2003,
Pubmed
Merk,
The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).
2011,
Pubmed
Noels,
Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.
2009,
Pubmed
Reif,
The CDM protein DOCK2 in lymphocyte migration.
2002,
Pubmed
Tillmann,
Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis.
2013,
Pubmed
Xin,
The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.
2010,
Pubmed
